Syndax (SNDX) CEO Metzger awarded RSUs, options and sells shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Syndax Pharmaceuticals Chief Executive Officer and director Michael A. Metzger reported multiple equity transactions. On February 4, 2026, he received 73,000 restricted stock units that vest in three equal annual installments, plus 144,600 performance-based RSUs whose payout depends on pre-set metrics. He was also granted stock options for 440,000 shares at an exercise price of $20.43 per share, vesting monthly over four years. On February 6, 2026, he sold 7,412 shares of common stock at $20.62 per share to cover tax withholding tied to RSU vesting, and after these transactions directly owned 508,849 common shares and 440,000 options.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 7,412 shares ($152,835)
Net Sell
4 txns
Insider
Metzger Michael A
Role
Chief Executive Officer
Sold
7,412 shs ($153K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 7,412 | $20.62 | $153K |
| Grant/Award | Stock Options (Right to buy) | 440,000 | $20.43 | $8.99M |
| Grant/Award | Common Stock | 73,000 | $0.00 | -- |
| Grant/Award | Common Stock | 144,600 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 508,849 shares (Direct);
Stock Options (Right to buy) — 440,000 shares (Direct)
Footnotes (1)
- Award of restricted stock units ("RSUs"), representing the right to receive one share of Common Stock for each RSU. One third (1/3rd) of the shares of Common Stock subject to such RSU shall vest annually on the anniversary of the Vesting Commencement Date, during the Reporting Person's continued service as an employee, consultant, director or officer of the Company over the three (3) years following the date of grant, until all of the shares subject to such RSU are fully vested. Award of RSUs, representing the right to receive one share of Common Stock for each RSU. The number of shares of Common Stock acquired upon vesting of the RSUs is contingent upon the achievement of pre-established performance metrics, as approved by the Company's Compensation Committee, subject to the Reporting Person's continued service as an employee, consultant, director or officer of the Company. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. 1/48th of the shares subject to the option shall vest monthly over a four-year period.
FAQ
What insider transactions did Syndax (SNDX) CEO Michael Metzger report?
Michael Metzger reported equity grants and a small share sale. He received time-based RSUs, performance-based RSUs, a large stock option grant, and sold 7,412 shares of common stock primarily to cover tax withholding obligations tied to RSU vesting.
How many RSUs did the Syndax (SNDX) CEO receive in this Form 4 filing?
Metzger received 73,000 time-based RSUs and 144,600 performance-based RSUs. The time-based RSUs vest in three equal annual installments, while the performance RSUs vest only if pre-established metrics approved by the Compensation Committee are achieved during his continued service.
What stock option grant was reported for the Syndax (SNDX) CEO?
He was granted stock options for 440,000 shares of Syndax common stock with a $20.43 exercise price. These options vest over four years, with 1/48th of the shares vesting each month, so long as Metzger continues in qualifying service with the company.
How do the performance-based RSUs for Syndax (SNDX) CEO vest?
The performance-based RSUs represent the right to receive one common share per unit upon vesting. The number of shares actually earned depends on achieving pre-established performance metrics set by the Compensation Committee and Metzger’s continued qualifying service with Syndax.